Cullinan Therapeutics Inc. – Filings and Transcripts

NASDAQ: CGEM
Share price (6/2/26): $15.34
Market cap (6/2/26): $943 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Automatic shelf registration

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration

Ownership Filter

Biotechnology Value Fund L P

Michaelson Jennifer

Michaelson Jennifer

Vanguard Group Inc

Michaelson Jennifer

News Filter

To Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress

Provides Corporate Update and Reports First Quarter 2026 Financial Results

Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results

Provides Corporate Update and Highlights Anticipated 2026 Milestones

Showcases Compelling Clinical Data in AML for CLN-049, Novel FLT3xCD3 T Cell Engager, in Oral Presentation at the 67th ASH Meeting

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC